privately held neorx corp said has entered into exclusive agreement with genentech inc for development injectable diagnostic image blood clots said genentech will responsible for marketing and neorx will receive royalties based sales product will proprietary neorx method attaching radioisotope technetium 99m genentech blood clot dissolving drug tissue plasminogen activator activase reuter 